Capstone Investment Advisors LLC Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Capstone Investment Advisors LLC boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 14.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,438 shares of the biotechnology company’s stock after buying an additional 178 shares during the period. Capstone Investment Advisors LLC’s holdings in Axon Enterprise were worth $575,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in AXON. Tidal Investments LLC raised its position in shares of Axon Enterprise by 22.4% during the 1st quarter. Tidal Investments LLC now owns 4,833 shares of the biotechnology company’s stock valued at $1,512,000 after buying an additional 884 shares in the last quarter. Cetera Investment Advisers boosted its holdings in shares of Axon Enterprise by 280.6% in the 1st quarter. Cetera Investment Advisers now owns 21,067 shares of the biotechnology company’s stock worth $6,592,000 after purchasing an additional 15,532 shares in the last quarter. Cetera Advisors LLC increased its position in shares of Axon Enterprise by 49.7% during the 1st quarter. Cetera Advisors LLC now owns 7,623 shares of the biotechnology company’s stock valued at $2,385,000 after purchasing an additional 2,532 shares during the last quarter. DekaBank Deutsche Girozentrale raised its stake in shares of Axon Enterprise by 45.4% during the first quarter. DekaBank Deutsche Girozentrale now owns 16,986 shares of the biotechnology company’s stock worth $5,321,000 after acquiring an additional 5,301 shares in the last quarter. Finally, Transcend Capital Advisors LLC purchased a new stake in shares of Axon Enterprise in the 2nd quarter valued at $206,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Jeri Williams sold 110 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the completion of the transaction, the director now directly owns 1,934 shares in the company, valued at $773,600. The trade was a 5.38 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 75,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total value of $26,739,750.00. Following the transaction, the chief executive officer now directly owns 2,970,366 shares in the company, valued at approximately $1,059,024,589.98. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 210,256 shares of company stock worth $87,783,120 in the last 90 days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 1.9 %

NASDAQ:AXON opened at $646.96 on Friday. The firm has a market capitalization of $49.33 billion, a P/E ratio of 167.17, a PEG ratio of 13.97 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $224.28 and a one year high of $652.22. The company’s 50-day simple moving average is $483.18 and its 200 day simple moving average is $376.61.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Robert W. Baird raised their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.